CLINICAL RESEARCH: ELECTROPHYSIOLOGY
Postmortem molecular screening in unexplained sudden death
Sumeet S. Chugh, MD*,*,
Olga Senashova, BS*,
Allison Watts, MS*,
Phuoc T. Tran, MD, PhD ,
Zhengfeng Zhou, MD, PhD ,
Qiuming Gong, MD, PhD,
Jack L. Titus, MD, PhD and
Susan J. Hayflick, MD
* Division of Cardiology, Portland, OregonUSA
Division of Molecular Medicine, Portland, OregonUSA
Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon, USA
Jesse E. Edwards Registry of Cardiovascular Disease, St. Paul, Minnesota, USA
Manuscript received October 8, 2003;
accepted November 6, 2003.
* Reprint requests and correspondence: Dr. Sumeet S. Chugh, Cardiology Division, UHN-62, Oregon Health Sciences University, 3181 S.W. Sam Jackson Park Road, Portland, Oregon 97239, USA.
chughs{at}ohsu.edu
OBJECTIVES: We examined the prevalence of defects in arrhythmia-related candidate genes among patients with unexplained sudden cardiac death (SCD).
BACKGROUND: Patients with unexplained sudden death may constitute up to 5% of overall SCD cases. For such patients, systematic postmortem genetic analysis of archived tissue, using a candidate gene approach, may identify etiologies of SCD.
METHODS: We performed analysis of KCNQ1 (KVLQT1), KCNH2 (HERG), SCN5A, KCNE1, and KCNE2 defects in a subgroup of 12 adult subjects with unexplained sudden death, derived from a 13-year, 270-patient autopsy series of SCD. Archived, paraffin-embedded myocardial tissue blocks obtained at the original postmortem examination were the source of deoxyribonucleic acid for genetic analysis.
RESULTS: Two patients were found to have the same HERG defect, a missense mutation in exon 7 (nucleotide change G1681A, coding effect A561T). The mutation was heterozygous in Patient 1, but Patient 2 appeared to be homozygous for the defect. Patch-clamp recordings showed that the A561T mutant channel expressed in human embryonic kidney cells failed to generate HERG current. Western blot analysis implicated a trafficking defect in the protein, resulting in loss of post-translational processing from the immature to the mature form of HERG. No mutations were detected among the remaining four candidate genes.
CONCLUSIONS: In this autopsy series, only 2 of 12 patients with unexplained sudden death were observed to have a defect in HERG among five candidate genes tested. It is likely that elucidation of SCD mechanisms in such patients will await the discovery of multiple, novel arrhythmia-causing gene defects.
|
Abbreviations and Acronyms
| | ECG | = electrocardiogram | | HEK | = human embryonic kidney | | LQTS | = long QT syndrome | | PCR | = polymerase chain reaction | | SCD | = sudden cardiac death | | SSCP | = single-stranded conformational polymorphism |
|
This article has been cited by other articles:
|
|
|
|
 
M. Eijgelsheim, A. L.H.J. Aarnoudse, F. Rivadeneira, J. A. Kors, J. C. M. Witteman, A. Hofman, C. M. van Duijn, A. G. Uitterlinden, and B. H.C. Stricker
Identification of a common variant at the NOS1AP locus strongly associated to QT-interval duration
Hum. Mol. Genet.,
January 15, 2009;
18(2):
347 - 357.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Noseworthy and C. Newton-Cheh
Genetic Determinants of Sudden Cardiac Death
Circulation,
October 28, 2008;
118(18):
1854 - 1863.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. C. Sexton and S. A. Metcalfe
Disclosing Genetic Research Results After Death of Pediatric Patients
JAMA,
October 8, 2008;
300(14):
1693 - 1695.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. R. Behr, C. Dalageorgou, M. Christiansen, P. Syrris, S. Hughes, M. T. Tome Esteban, E. Rowland, S. Jeffery, and W. J. McKenna
Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families
Eur. Heart J.,
July 1, 2008;
29(13):
1670 - 1680.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Byrne, O. Constant, Y. Smyth, G. Callagy, P. Nash, K. Daly, and J. Crowley
Multiple source surveillance incidence and aetiology of out-of-hospital sudden cardiac death in a rural population in the West of Ireland
Eur. Heart J.,
June 1, 2008;
29(11):
1418 - 1423.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Heart Rhythm UK Familial Sudden Death Syndromes St
Clinical indications for genetic testing in familial sudden cardiac death syndromes: an HRUK position statement
Heart,
April 1, 2008;
94(4):
502 - 507.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. W. Van Norstrand, C. R. Valdivia, D. J. Tester, K. Ueda, B. London, J. C. Makielski, and M. J. Ackerman
Molecular and Functional Characterization of Novel Glycerol-3-Phosphate Dehydrogenase 1-Like Gene (GPD1-L) Mutations in Sudden Infant Death Syndrome
Circulation,
November 13, 2007;
116(20):
2253 - 2259.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Newton-Cheh, C.-Y. Guo, M. G. Larson, S. L. Musone, A. Surti, A. L. Camargo, J. A. Drake, E. J. Benjamin, D. Levy, R. B. D'Agostino Sr, et al.
Common Genetic Variation in KCNH2 Is Associated With QT Interval Duration: The Framingham Heart Study
Circulation,
September 4, 2007;
116(10):
1128 - 1136.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E R Behr, A Casey, M Sheppard, M Wright, T J Bowker, M J Davies, W J McKenna, and D A Wood
Sudden arrhythmic death syndrome: a national survey of sudden unexplained cardiac death
Heart,
May 1, 2007;
93(5):
601 - 605.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Tester and M. J. Ackerman
Postmortem Long QT Syndrome Genetic Testing for Sudden Unexplained Death in the Young
J. Am. Coll. Cardiol.,
January 16, 2007;
49(2):
240 - 246.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Q. Gong, M. A. Jones, and Z. Zhou
Mechanisms of Pharmacological Rescue of Trafficking-defective hERG Mutant Channels in Human Long QT Syndrome
J. Biol. Chem.,
February 17, 2006;
281(7):
4069 - 4074.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. L. Anderson, B. P. Delisle, B. D. Anson, J. A. Kilby, M. L. Will, D. J. Tester, Q. Gong, Z. Zhou, M. J. Ackerman, and C. T. January
Most LQT2 Mutations Reduce Kv11.1 (hERG) Current by a Class 2 (Trafficking-Deficient) Mechanism
Circulation,
January 24, 2006;
113(3):
365 - 373.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Liu, R. Wang, J. Zhang, S. R. W. Chen, and T. Wagenknecht
Localization of a Disease-associated Mutation Site in the Three-dimensional Structure of the Cardiac Muscle Ryanodine Receptor
J. Biol. Chem.,
November 11, 2005;
280(45):
37941 - 37947.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. P. Delisle, J. K. Slind, J. A. Kilby, C. L. Anderson, B. D. Anson, R. C. Balijepalli, D. J. Tester, M. J. Ackerman, T. J. Kamp, and C. T. January
Intragenic Suppression of Trafficking-Defective KCNH2 Channels Associated with Long QT Syndrome
Mol. Pharmacol.,
July 1, 2005;
68(1):
233 - 240.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. H. T. Wehrens and A. R. Marks
Sudden Unexplained Death Caused by Cardiac Ryanodine Receptor (RyR2) Mutations
Mayo Clin. Proc.,
November 1, 2004;
79(11):
1367 - 1371.
[PDF]
|
|
|
|
|
|
|
D. J. Tester, D. B. Spoon, H. H. Valdivia, J. C. Makielski, and M. J. Ackerman
Targeted Mutational Analysis of the RyR2-Encoded Cardiac Ryanodine Receptor in Sudden Unexplained Death: A Molecular Autopsy of 49 Medical Examiner/Coroner's Cases
Mayo Clin. Proc.,
November 1, 2004;
79(11):
1380 - 1384.
[Abstract]
[PDF]
|
|
|
|
